152 related articles for article (PubMed ID: 26401941)
1. Differential Effects of Meal Challenges on Cognition, Metabolism, and Biomarkers for Apolipoprotein E ɛ4 Carriers and Adults with Mild Cognitive Impairment.
Hanson AJ; Bayer JL; Baker LD; Cholerton B; VanFossen B; Trittschuh E; Rissman RA; Donohue MC; Moghadam SH; Plymate SR; Craft S
J Alzheimers Dis; 2015; 48(1):205-18. PubMed ID: 26401941
[TBL] [Abstract][Full Text] [Related]
2. Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial.
Hanson AJ; Bayer-Carter JL; Green PS; Montine TJ; Wilkinson CW; Baker LD; Watson GS; Bonner LM; Callaghan M; Leverenz JB; Tsai E; Postupna N; Zhang J; Lampe J; Craft S
JAMA Neurol; 2013 Aug; 70(8):972-80. PubMed ID: 23779114
[TBL] [Abstract][Full Text] [Related]
3. Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive Impairment Subtypes and Interaction with APOE ɛ4 Genotype.
Bangen KJ; Clark AL; Werhane M; Edmonds EC; Nation DA; Evangelista N; Libon DJ; Bondi MW; Delano-Wood L;
J Alzheimers Dis; 2016 Mar; 52(3):849-61. PubMed ID: 27031472
[TBL] [Abstract][Full Text] [Related]
4. Arterial spin labeling imaging reveals widespread and Aβ-independent reductions in cerebral blood flow in elderly apolipoprotein epsilon-4 carriers.
Michels L; Warnock G; Buck A; Macauda G; Leh SE; Kaelin AM; Riese F; Meyer R; O'Gorman R; Hock C; Kollias S; Gietl AF
J Cereb Blood Flow Metab; 2016 Mar; 36(3):581-95. PubMed ID: 26661143
[TBL] [Abstract][Full Text] [Related]
5. Amyloid-β related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adults.
Hollands S; Lim YY; Buckley R; Pietrzak RH; Snyder PJ; Ames D; Ellis KA; Harrington K; Lautenschlager N; Martins RN; Masters CL; Villemagne VL; Rowe CC; Maruff P
J Alzheimers Dis; 2015; 43(2):677-86. PubMed ID: 25114076
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
7. Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia.
Claxton A; Baker LD; Hanson A; Trittschuh EH; Cholerton B; Morgan A; Callaghan M; Arbuckle M; Behl C; Craft S
J Alzheimers Dis; 2015; 44(3):897-906. PubMed ID: 25374101
[TBL] [Abstract][Full Text] [Related]
8. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
9. APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease.
Lim YY; Villemagne VL; Pietrzak RH; Ames D; Ellis KA; Harrington K; Snyder PJ; Martins RN; Masters CL; Rowe CC; Maruff P;
Neurobiol Aging; 2015 Mar; 36(3):1239-44. PubMed ID: 25559335
[TBL] [Abstract][Full Text] [Related]
10. Cerebral and blood correlates of reduced functional connectivity in mild cognitive impairment.
Gonzalez-Escamilla G; Atienza M; Garcia-Solis D; Cantero JL
Brain Struct Funct; 2016 Jan; 221(1):631-45. PubMed ID: 25366971
[TBL] [Abstract][Full Text] [Related]
11. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.
Foster JK; Albrecht MA; Savage G; Lautenschlager NT; Ellis KA; Maruff P; Szoeke C; Taddei K; Martins R; Masters CL; Ames D;
Brain; 2013 Jul; 136(Pt 7):2201-16. PubMed ID: 23737466
[TBL] [Abstract][Full Text] [Related]
12. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
13. Dietary fats and the APOE-e4 risk allele in relation to cognitive decline: a longitudinal investigation in a biracial population sample.
Liu X; Beck T; Dhana K; Tangney CC; Desai P; Krueger K; Evans DA; Rajan KB
J Nutr Health Aging; 2024 May; 28(5):100211. PubMed ID: 38507884
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Alzheimer's Disease and Mild Cognitive Impairment in Older Adults in Panama.
Villarreal AE; Grajales S; O'Bryant SE; Edwards M; López L; Montalván A; Britton GB;
J Alzheimers Dis; 2016 Oct; 54(3):897-901. PubMed ID: 27567849
[TBL] [Abstract][Full Text] [Related]
15. APOE ɛ4 constrains engagement of encoding-related compensatory networks in amnestic mild cognitive impairment.
Prieto del Val L; Cantero JL; Atienza M
Hippocampus; 2015 Sep; 25(9):993-1007. PubMed ID: 25616215
[TBL] [Abstract][Full Text] [Related]
16. Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment.
Cechova K; Andel R; Angelucci F; Chmatalova Z; Markova H; Laczó J; Vyhnalek M; Matoska V; Kaplan V; Nedelska Z; Ward DD; Hort J
J Alzheimers Dis; 2020; 73(1):247-257. PubMed ID: 31771052
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment.
Viticchi G; Falsetti L; Vernieri F; Altamura C; Altavilla R; Luzzi S; Bartolini M; Provinciali L; Silvestrini M
J Alzheimers Dis; 2014; 41(2):401-10. PubMed ID: 24625799
[TBL] [Abstract][Full Text] [Related]
18. Progression from MCI to AD: predictive value of CSF Aβ42 is modified by APOE genotype.
Kester MI; Verwey NA; van Elk EJ; Blankenstein MA; Scheltens P; van der Flier WM
Neurobiol Aging; 2011 Aug; 32(8):1372-8. PubMed ID: 19748159
[TBL] [Abstract][Full Text] [Related]
19. Association between cognitive function and plasma lipids of the elderly after controlling for apolipoprotein E genotype.
Yasuno F; Tanimukai S; Sasaki M; Hidaka S; Ikejima C; Yamashita F; Kodama C; Mizukami K; Michikawa M; Asada T
Am J Geriatr Psychiatry; 2012 Jul; 20(7):574-83. PubMed ID: 21407046
[TBL] [Abstract][Full Text] [Related]
20. Decreased cerebrospinal fluid levels of L-carnitine in non-apolipoprotein E4 carriers at early stages of Alzheimer's disease.
Lodeiro M; Ibáñez C; Cifuentes A; Simó C; Cedazo-Mínguez Á
J Alzheimers Dis; 2014; 41(1):223-32. PubMed ID: 24595197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
